Zimmer Biomet Holdings, Inc. (SWX:ZBH)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
78.00
0.00 (0.00%)
At close: Oct 17, 2025
Market Cap16.11B
Revenue (ttm)6.23B
Net Income (ttm)654.91M
Shares Outn/a
EPS (ttm)3.27
PE Ratio24.59
Forward PE12.30
Dividend0.81 (1.04%)
Ex-Dividend DateSep 30, 2025
Volumen/a
Average Volume1
Openn/a
Previous Close78.00
Day's Rangen/a
52-Week Range71.81 - 119.00
Beta1.01
RSI80.45
Earnings DateNov 5, 2025

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open hear... [Read more]

Sector Healthcare
Founded 1927
Employees 17,000
Stock Exchange SIX Swiss Exchange
Ticker Symbol ZBH
Full Company Profile

Financial Performance

In 2024, Zimmer Biomet Holdings's revenue was $7.68 billion, an increase of 3.85% compared to the previous year's $7.39 billion. Earnings were $903.80 million, a decrease of -11.74%.

Financial numbers in USD Financial Statements

News

BTIG Raises Price Target for Zimmer Biomet Holdings (ZBH) to $122 | ZBH Stock News

BTIG Raises Price Target for Zimmer Biomet Holdings (ZBH) to $122 | ZBH Stock News

8 days ago - GuruFocus

The New Compact

The dynamic between the employee and employer has had some wild swings over the past several years. Forward-looking organizations are finding a new equilibrium, meeting the needs of their people while...

13 days ago - CNBC

Zimmer Biomet And Paragon 28 Launch Two New Foot And Ankle Trauma Solutions

(RTTNews) - Zimmer Biomet Holdings Inc. (ZBH) and its subsidiary Paragon 28 on Wednesday announced the commercial launch of two new products for complex foot and ankle trauma: the Gorilla Pilon Fusion...

13 days ago - Nasdaq

Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases

Gorilla® Pilon Fusion Plating System Introduced for Complex Ankle Fusions Phantom® TTC Trauma Nail Enhances Treatment Options for Complex Hindfoot Injuries WARSAW, Ind., Oct. 8, 2025 /PRNewswire/ -- Z...

13 days ago - PRNewsWire

Zimmer Biomet Holdings (ZBH) Completes Merger with Monogram Technologies

Zimmer Biomet Holdings (ZBH) Completes Merger with Monogram Technologies

13 days ago - GuruFocus

Evercore ISI Group Lowers Price Target for Zimmer Biomet Holdings (ZBH) | ZBH Stock News

Evercore ISI Group Lowers Price Target for Zimmer Biomet Holdings (ZBH) | ZBH Stock News

14 days ago - GuruFocus

Zimmer Biomet (ZBH) Finalizes Acquisition of Monogram Technologies for $177M

Zimmer Biomet (ZBH) Finalizes Acquisition of Monogram Technologies for $177M

14 days ago - GuruFocus

Zimmer Biomet (ZBH) Finalizes Acquisition of Monogram Technologies

Zimmer Biomet (ZBH) Finalizes Acquisition of Monogram Technologies

14 days ago - GuruFocus

Zimmer Biomet Completes Acquisition Of Monogram

(RTTNews) - Zimmer Biomet Holdings, Inc. (ZBH) has completed the acquisition of Monogram Technologies, an AI-driven, next-generation orthopedic robotics company. The acquisition expands Zimmer Biomet'...

14 days ago - Nasdaq

Zimmer Biomet Completes Acquisition of Monogram Technologies

Transaction creates the  broadest, most flexible portfolio of orthopedic robotics and navigation technologies, including pathway towards the first fully autonomous robotic technology for orthopedic pr...

14 days ago - PRNewsWire

I2Pure Celebrates Zimmer Biomet's Historic Approval of Iodine-Treated Implant System & Confirms AAHKS Attendance

ASHBURN, Va.--(BUSINESS WIRE)--I2Pure, a leader in molecular iodine technology, today celebrates Zimmer Biomet's recent achievement in receiving Japan's Pharmaceutical and Medical Devices Agency (PMDA...

15 days ago - Business Wire

Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2025 Financial Results

WARSAW, Ind. , Oct. 3, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter earnings conference call will be webcast on Wednesday, November 5, 2025 a...

18 days ago - PRNewsWire

ZBH Receives PMDA Approval in Japan for iTaperloc Complete and iG7

Zimmer Biomet wins early PMDA approval in Japan for its iTaperloc Complete and iG7 Hip System with Iodine Technology.

19 days ago - Nasdaq

Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

19 days ago - Nasdaq

Looking Into Zimmer Biomet Holdings Inc's Recent Short Interest

Zimmer Biomet Holdings Inc's (NYSE: ZBH) short interest as a percent of float has risen 13.1% since its last report. According to exchange reported data, there are now 6.57 million shares sold short ...

21 days ago - Benzinga

Ex-Dividend Reminder: National Fuel Gas, Zimmer Biomet Holdings and National Healthcare

Looking at the universe of stocks we cover at Dividend Channel, on 9/30/25, National Fuel Gas Co. (Symbol: NFG), Zimmer Biomet Holdings Inc (Symbol: ZBH), and National Healthcare Corp. (Symbol: NHC) w...

25 days ago - Nasdaq

Zimmer Biomet (ZBH) Gains Japanese Approval for Innovative Iodine-Infused Implants

Zimmer Biomet (ZBH) Gains Japanese Approval for Innovative Iodine-Infused Implants

26 days ago - GuruFocus

Zimmer Biomet Announces Japan PMDA Approval of World's First Iodine-Treated Total Hip Replacement System

iTaperloc® Complete and iG7™ Hip System with Iodine Technology inhibits bacterial adhesion and prevents biofilm formation on the implant surface to help address the issue of Periprosthetic Joint Infec...

26 days ago - PRNewsWire

All You Need to Know About Zimmer (ZBH) Rating Upgrade to Buy

Zimmer (ZBH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

4 weeks ago - Nasdaq

Stifel Maintains Buy Rating on Zimmer Biomet Holdings (ZBH), Raises Price Target | ZBH Stock News

Stifel Maintains Buy Rating on Zimmer Biomet Holdings (ZBH), Raises Price Target | ZBH Stock News

4 weeks ago - GuruFocus

Zimmer Biomet Holdings (ZBH) Receives 'Buy' Rating from Rothschild & Co | ZBH Stock News

Zimmer Biomet Holdings (ZBH) Receives 'Buy' Rating from Rothschild & Co | ZBH Stock News

4 weeks ago - GuruFocus

How To YieldBoost Zimmer Biomet Holdings To 7.7% Using Options

Shareholders of Zimmer Biomet Holdings Inc (Symbol: ZBH) looking to boost their income beyond the stock's 1% annualized dividend yield can sell the January 2027 covered call at the $110 strike and col...

5 weeks ago - Nasdaq

Insider Decision: Sang Yi Offloads $124K Worth Of Zimmer Biomet Holdings Stock

Sang Yi , Group President at Zimmer Biomet Holdings (NYSE: ZBH), disclosed an insider sell on September 15, according to a recent SEC filing. What Happened: Yi's decision to sell 1,200 shares of Zimm...

5 weeks ago - Benzinga